top of page
All Posts


Tina Witte
Feb 73 min read
January 2025 Biotech Highlights: What’s Ahead for 2025 post-JPMorgan
The energy, excitement, and deal volumes at this year’s JPM Morgan Healthcare conference always set the tone for what is to come in the...


Gordon Donkin
Feb 62 min read
Notes from the UK office of Fletcher
“What a collapse! What a miss!”—No, I am not talking about the English cricket team. I am referring to the stunning drop in the value of...
bottom of page